The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

By Alimohammadian M.H.   Khamesipour A.   Darabi H.   Firooz A.   Malekzadeh S.   Bahonar A.   Dowlati Y.   Modabber F.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 174-180

Elsevier

Access to resources Recommend Favorite

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

By Ghosh A.   Labrecque S.   Matlashewski G.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3169-3178

Elsevier

Access to resources Recommend Favorite

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice

By Lopez-Fuertes L.   Perez-Jimenez E.   Vila-Coro A.J.   Sack F.   Moreno S.   Konig S.A.   Junghans C.   Wittig B.   Timon M.   Esteban M.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 247-257

Elsevier

Access to resources Recommend Favorite

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

By Paraguai de Souza E.   Bernardo R.R.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3104-3115

Elsevier

Access to resources Recommend Favorite

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani

By Santos W.R.   Paraguai de Souza E.   Palatnik M.   Palatnik de Sousa C.B.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2554-2561

Elsevier

Access to resources Recommend Favorite